Back

P300-mediated inactivation of p53 protects against doxorubicin-induced cardiotoxicity

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Basic science heart failure Cardiotoxicity of Drugs and Other Therapies ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Mohamed Adam

St. Michael's Hospital, Toronto (Canada)

9 More presentations in this session

Presentation thumbnail
Doctor M. Hossain (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Associate Professor Y. Suematsu (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
Professor R. Okamoto (Tsu, JP)
Abstract
Presentation thumbnail
Professor G. Tse (Hong Kong, CN)
Abstract
Presentation thumbnail
Doctor T. Lin (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Basic science heart failure

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Rare causes of heart failure
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources